Notably, patients with acute or chronic myeloid leukemia presented low expression levels of JunB, increasing studies suggested JunB affect cell cycle and differentiation through transcriptionally activating essential genes. Here, JUNB is linked to chronic myelogenous leukemia, BCR-ABL1 positive.